Target intelligence / Profile preview

Dentino-enamel junction (DEJ)

Target
DEJ
Molecular classification
Other
01

Overview

The **dentino-enamel junction** (DEJ) is the complex interface where **enamel**—the hardest and most mineralized tissue of the tooth—meets the underlying **dentin**, a slightly softer and less mineralized tissue[1][2][3][4]. The DEJ is not a discrete molecule or receptor but a structural boundary with unique architecture crucial for mechanical robustness of the tooth. It is characterized by a supramolecular assembly of mineral (hydroxyapatite crystals), collagen fibrils from dentin, and specific enamel and dentin extracellular matrix proteins (such as amelogenin, enamelin, and dentin matrix acidic phosphoprotein 1)[1]. This interface dissipates mechanical stress, provides crack resistance, and integrates two mechanically contrasting tissues—hard enamel and flexible dentin—ensuring long-term durability under repeated occlusal forces[1][3][4][5]. **Note:** - The "tooth enamel/dentin mineral interface" is not a single gene, receptor, or druggable molecular entity, but a histological and biomechanical region, making it unsuitable as a classical therapeutic target. - Any search for interacting drugs, biomarkers, or targeted therapies is not applicable[1][2][3][4][5]. - If a molecular target within this interface is needed, consider components like "Amelogenin", "Dentin matrix protein 1", or enzymes like "Matrix metalloproteinase-20 (MMP20)", which participate in enamel or dentin matrix modulation.

Other names
dentin-enamel junctionenamel-dentin junctionenamel/dentin mineral interface
02

Biological functions

Mineral integrationStructural integrityMechanical resilience
03

Disease associations

Other

Beyond the preview

Go deeper on Dentino-enamel junction (DEJ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dentino-enamel junction (DEJ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call